{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:26:12Z","timestamp":1781526372119,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","physicamedica.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physica Medica"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejmp.2026.105772","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:15:21Z","timestamp":1774286121000},"page":"105772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A phantom study to achieve comparable 124I PET recovery and address scanner variability for dosimetry purposes in (re)differentiated thyroid cancer"],"prefix":"10.1016","volume":"145","author":[{"given":"Maaike","family":"Dotinga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lioe-Fee","family":"de Geus-Oei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0538-8270","authenticated-orcid":false,"given":"Petra","family":"Dibbets-Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2843-1854","authenticated-orcid":false,"given":"Mette K.","family":"Stam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Pool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka M.","family":"Pereira Arias-Bouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4814-6426","authenticated-orcid":false,"given":"Ellen","family":"Kapiteijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5762-6766","authenticated-orcid":false,"given":"Dennis","family":"Vriens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris H.P.","family":"van Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejmp.2026.105772_b0005","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/thy.2021.0565","article-title":"Enhancing radioiodine incorporation in BRAF-mutant, radioiodine-refractory thyroid cancers with vemurafenib and the anti-ErbB3 monoclonal antibody CDX-3379: results of a pilot clinical trial","volume":"32","author":"Tchekmedyian","year":"2022","journal-title":"Thyroid"},{"issue":"19","key":"10.1016\/j.ejmp.2026.105772_b0010","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1158\/1078-0432.CCR-22-0437","article-title":"Enhancing radioiodine incorporation into radioiodine-refractory thyroid cancer with MAPK inhibition (ERRITI): a single-center prospective two-arm study","volume":"28","author":"Weber","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.ejmp.2026.105772_b0015","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1056\/NEJMoa1209288","article-title":"Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer","volume":"368","author":"Ho","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejmp.2026.105772_b0020","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1210\/jc.2018-01478","article-title":"Vemurafenib redifferentiation of BRAF mutant, RAI-refractory thyroid cancer","volume":"104","author":"Dunn","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ejmp.2026.105772_b0025","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1089\/thy.2019.0143","article-title":"Mitogen-activated protein kinase pathway inhibition for redifferentiation of radioiodine refractory differentiated thryoid cancer: an evolving protocol","volume":"29","author":"Iravani","year":"2019","journal-title":"Thyroid Cancer Nodules"},{"issue":"6","key":"10.1016\/j.ejmp.2026.105772_b0030","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1530\/EJE-09-0702","article-title":"Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma","volume":"161","author":"Hoftijzer","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.ejmp.2026.105772_b0035","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1210\/jc.2018-00612","article-title":"Targeted therapy in advanced thyroid cancer to resensitize tumors to radioactive radioiodine","volume":"103","author":"Jaber","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ejmp.2026.105772_b0040","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-24-0153","article-title":"Digoxin treatment does not reinduce radioiodine uptake in radioiodine refractory non-medullary thyroid carcinoma","volume":"13","author":"van Houten","year":"2024","journal-title":"Eur Thyroid J"},{"issue":"5","key":"10.1016\/j.ejmp.2026.105772_b0045","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1158\/1078-0432.CCR-14-2915","article-title":"Redifferentation of iodine-refractory BRAF V600E-mutant metastatic papillary thyroid cancer with dabrafenib","volume":"21","author":"Rothenberg","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"13","key":"10.1016\/j.ejmp.2026.105772_b0050","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1158\/1078-0432.CCR-23-0046","article-title":"A phase II redifferentiation trial with dabrafenib-trametinib and 131I in metastatic radioactive iodine refractory BRAF p.V600E-mutated differentiated thyroid cancer","volume":"29","author":"Leboulleux","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejmp.2026.105772_b0055","doi-asserted-by":"crossref","first-page":"250","DOI":"10.23736\/S1824-4785.20.03264-1","article-title":"Managing radioiodine refractory thyroid cancer: the role of dosimetry and redifferentiation on subsequent I-131 therapy","volume":"64","author":"Dotinga","year":"2020","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105772_b0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.23736\/S1824-4785.19.03201-1","article-title":"The role of I-124 PET\/CT lesion dosimetry in differentiated thyroid cancer","volume":"63","author":"Weber","year":"2019","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmp.2026.105772_b0065","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4274\/2017.26.suppl.07","article-title":"I-124 imaging and dosimetry","volume":"26","author":"Kuker","year":"2017","journal-title":"Mol Imaging Radionucl Ther"},{"issue":"9","key":"10.1016\/j.ejmp.2026.105772_b0070","doi-asserted-by":"crossref","first-page":"E1382","DOI":"10.3390\/cancers11091382","article-title":"Radioiodine-refractory thryoid cancer: molecular basis of redifferentation therapies, management and novel therapies","volume":"11","author":"Aashiq","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmp.2026.105772_b0075","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3067123","article-title":"Comparison of imaging characteristics of (124)I PET for determination of optimal energy window on the siemens Inveon PET","volume":"2016","author":"Yu","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ejmp.2026.105772_b0080","unstructured":"Tan-Phan, T.T.H. 124I PET\/CT in Thyroid Cancer. 2016; Available from: https:\/\/richtlijnendatabase.nl\/gerelateerde_documenten\/f\/17259\/124I%20PETCT%20in%20Thyroid%20Cancer.pdf (accessed on 17-8-2025)."},{"issue":"6","key":"10.1016\/j.ejmp.2026.105772_b0085","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2967\/jnumed.107.047159","article-title":"Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer","volume":"49","author":"Jentzen","year":"2008","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105772_b0090","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105772_b0095","first-page":"8","article-title":"Physics of pure and non-pure positron emitters for PET: a review and a discussion","volume":"3","author":"Conti","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging Phys"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105772_b0100","first-page":"21","article-title":"Quantitative imaging of (124)I with PET\/ CT in pretherapy lesion dosimetry. Effects impairing image quantification and their corrections","volume":"55","author":"Jentzen","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"10.1016\/j.ejmp.2026.105772_b0105","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1007\/s00259-011-1768-2","article-title":"Quantitative imaging of 124I and 86Y with PET","volume":"38 Suppl 1","author":"Lubberink","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105772_b0110","doi-asserted-by":"crossref","first-page":"17477","DOI":"10.1038\/s41598-021-95719-8","article-title":"Silicon-photomultiplier-based PET\/CT reduces the minimum detectable activity of iodine-124","volume":"11","author":"Kersting","year":"2021","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.ejmp.2026.105772_b0115","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1210\/jc.2015-3989","article-title":"Characterization of tumor size changes over time from the phase 3 study of lenvatinib in thyroid cancer","volume":"101","author":"Robinson","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ejmp.2026.105772_b0120","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1507\/endocrj.EJ17-0104","article-title":"Lenvatinib induces early tumor shrinkage in patients with advanced thyroid carcinoma","volume":"64","author":"Masaki","year":"2017","journal-title":"Endocr J"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105772_b0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40658-021-00361-y","article-title":"Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancer","volume":"8","author":"Kersting","year":"2021","journal-title":"EJNMMI Phys"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105772_b0130","first-page":"R161","article-title":"Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(\/CT) systems","volume":"17","author":"Jentzen","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmp.2026.105772_b0135","unstructured":"EANM. EARL PET\/CT Accreditation User Manual. Version 4.2. 2023; Available from: https:\/\/earl.eanm.org\/wp-content\/uploads\/2023\/05\/EARL_Manual_4.2.pdf (accessed on 25-3-2025)."},{"issue":"1","key":"10.1016\/j.ejmp.2026.105772_b0140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40658-018-0226-7","article-title":"Feasibility of PET\/CT system performance harmonisation for quantitative multicentre (89)Zr studies","volume":"5","author":"Kaalep","year":"2018","journal-title":"EJNMMI Phys"},{"issue":"4","key":"10.1016\/j.ejmp.2026.105772_b0145","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2967\/jnumed.118.215541","article-title":"Performance evaluation of the Vereos PET\/CT system according to the NEMA NU2-2012 standard","volume":"60","author":"Rausch","year":"2019","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.ejmp.2026.105772_b0150","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00259-023-06514-8","article-title":"An extended bore length solid-state digital-BGO PET\/CT system: design, preliminary experience, and performance characteristics","volume":"51","author":"Kennedy","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105772_b0155","first-page":"27","article-title":"Spatial resolution and image qualities of Zr-89 on siemens biograph TruePoint PET\/CT","volume":"30","author":"Lee","year":"2015","journal-title":"Cancer Biother Radiopharm"},{"issue":"12","key":"10.1016\/j.ejmp.2026.105772_b0160","article-title":"Reinducing radioiodine-sensitivity in radioiodine-refractory thyroid cancer using lenvatinib (RESET): Study protocol for a single-center, open label phase II trial","volume":"12","author":"Dotinga","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ejmp.2026.105772_bib231","doi-asserted-by":"crossref","unstructured":"Dotinga M., et al. No reinduction of clinically relevant radioiodine uptake after lenvatinib treatment in radioidine-refractory differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2025 Dec 16. doi: 10.1007\/s00259-025-07662-9. Epub ahead of print. PMID: 41398087.","DOI":"10.1007\/s00259-025-07662-9"},{"key":"10.1016\/j.ejmp.2026.105772_b0165","unstructured":"Boellaard R, et al. EARL procedure for assessing PET\/CT system specific patient FDG activity preparations for quantitative FDG PET\/CT studies. 2013; Available from: https:\/\/eanm-earl-wordpress.esh.netkey.at\/wp-content\/uploads\/2021\/04\/EARL-procedure-for-optimizing-FDG-activity-for-quantitative-FDG-PET-studies_version_1_1.pdf (accessed on 25-03-2025)."},{"issue":"8","key":"10.1016\/j.ejmp.2026.105772_b0170","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2967\/jnumed.115.156711","article-title":"Beyond 18F-FDG: characterization of PET\/CT and PET\/MR scanners for a comprehensive set of positron emitters of growing application\u201318F, 11C, 89Zr, 124I, 68Ga, and 90Y","volume":"56","author":"Soderlund","year":"2015","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.ejmp.2026.105772_b0175","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00259-009-1099-8","article-title":"Optimization and assessment of quantitative 124I imaging on a Philips Gemini dual GS PET\/CT system","volume":"36","author":"Gregory","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.ejmp.2026.105772_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071729","article-title":"Is the image quality of I-124-PET impaired by an automatic correction of prompt gammas?","volume":"8","author":"Preylowski","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ejmp.2026.105772_b0185","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1088\/0031-9155\/55\/8\/016","article-title":"Experimental investigation of factors affecting the absolute recovery coefficients in iodine-124 PET lesion imaging","volume":"55","author":"Jentzen","year":"2010","journal-title":"Phys Med Biol"},{"issue":"9","key":"10.1016\/j.ejmp.2026.105772_b0190","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1088\/0031-9155\/60\/9\/3479","article-title":"PET imaging with the non-pure positron emitters: (55)Co, (86)Y and (124)I","volume":"60","author":"Braad","year":"2015","journal-title":"Phys Med Biol"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105772_b0195","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40658-022-00482-y","article-title":"Positron range in combination with point-spread-function correction: an evaluation of different implementations for [124I]-PET imaging","volume":"9","author":"Kert\u00e9sz","year":"2022","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmp.2026.105772_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.818463","article-title":"Implementation of a spatially-variant and tissue-dependent positron range correction for PET\/CT imaging","volume":"13","author":"Kert\u00e9sz","year":"2022","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105772_b0205","first-page":"108","article-title":"Segmentation of PET volumes by iterative image thresholding","volume":"48","author":"Jentzen","year":"2007","journal-title":"J Nucl Med"},{"issue":"13","key":"10.1016\/j.ejmp.2026.105772_b0210","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1007\/s00259-018-4136-7","article-title":"EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations","volume":"45","author":"Gear","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105772_b0215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40658-020-00338-3","article-title":"An international multi-center investigation on the accuracy of radionuclide calibrators in nuclear medicine theragnostics","volume":"7","author":"Saldarriaga Vargas","year":"2020","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmp.2026.105772_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2023.103149","article-title":"Quantification performance of silicon photomultiplier-based PET for small (18)F-, (68)Ga- and (124)I-avid lesions in the context of radionuclide therapy planning","volume":"114","author":"Kersting","year":"2023","journal-title":"Phys Med"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105772_b0225","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13550-016-0191-x","article-title":"Calibration of PET\/CT scanners for multicenter studies on differentiated thyroid cancer with 124I","volume":"6","author":"Kist","year":"2016","journal-title":"EJNMMI Res"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105772_b0230","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40658-022-00512-9","article-title":"Quantification and dosimetry of small volumes including associated uncertainty estimation","volume":"9","author":"Carnegie-Peake","year":"2022","journal-title":"EJNMMI Phys"}],"container-title":["Physica Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179726000591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179726000591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:47:59Z","timestamp":1776772079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1120179726000591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":47,"alternative-id":["S1120179726000591"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmp.2026.105772","relation":{},"ISSN":["1120-1797"],"issn-type":[{"value":"1120-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phantom study to achieve comparable 124I PET recovery and address scanner variability for dosimetry purposes in (re)differentiated thyroid cancer","name":"articletitle","label":"Article Title"},{"value":"Physica Medica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmp.2026.105772","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105772"}}